Mountain Valley MD Holdings Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Dennis Hancock
- Full Time Employees
- 1
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 260 Edgeley Boulevard Concord ON Canada L4K 3Y4
- IPO Date
- May 19, 2020
- CIK
- 0001806862
- Website
- mountainvalleymd.com
- Similar Companies
- Business
- Mountain Valley MD Holdings Inc. (Ticker: MVMDF) develops and commercializes plant-based therapeutic products focused on oral health, chronic pain management, and functional mushroom formulations for the health and wellness sector. The company offers a portfolio of advanced botanical therapeutics, including its flagship non-opioid pain relief spray MVMD-100 series utilizing NanoCeutix™ liposomal delivery technology for rapid transmucosal absorption; preventive oral care solutions such as the Mountain Valley MD Oral Care Kit, featuring herbal-based toothpaste, mouthwash, and whitening strips; and functional mushroom beverages and extracts under the Mountain Valley Mushrooms brand, targeting immune support, cognitive enhancement, and stress reduction. These products emphasize nano-encapsulation and hydrogel technologies to enhance bioavailability and efficacy, serving consumer markets through e-commerce, retail partnerships, and direct-to-consumer channels. Founded in 2018 and headquartered in Calgary, Alberta, Canada, the company operates primarily in North America with distribution expanding into Europe and select Asian markets, targeting health-conscious consumers, dental professionals, and wellness retailers. Mountain Valley MD segments its business into oral health therapeutics, topical and mucosal pain relief products, and mycology-based functional foods and beverages. In the past two years, the company has pursued strategic growth through key developments, including the launch of its rebranded functional mushroom line under Mountain Valley Mushrooms in 2024, featuring innovative products like Calm Mushroom Cocoa and Focus Mushroom Coffee; a partnership with a leading European distributor announced in early 2025 to accelerate oral care product penetration; and the completion of a CAD 2.5 million private placement funding round in late 2024 to support R&D expansion and production scaling. Additionally, Mountain Valley MD advanced its NanoCeutix™ platform with pilot clinical data releases in 2025 demonstrating superior pain relief efficacy, positioning it for potential FDA pathway submissions, while streamlining operations via a corporate reorganization that consolidated mycology assets for enhanced focus on high-margin therapeutics.
Mountain Valley MD Advances Quicksome™ Sublingual Delivery Platform for Compounded Peptide Applications, Reports on Initial Formulation Work Across Multiple Peptides Including BPC-157
CORRECTING and REPLACING Mountain Valley MD Announces Appointment of Advisors and Stock Option Grants
Mountain Valley MD Announces Appointment of Advisors and Stock Option Grants
Mountain Valley MD Announces Closing of Non-Brokered Private Placement of Units and Concurrent Shares for Debt Transactions
Mountain Valley MD Announces Strategic Non-Brokered Private Placement of Units and Concurrent Shares for Debt Transaction
Mountain Valley MD Provides Year-End Business Update, Advances Commercialization Across Core Platforms
Mountain Valley MD Confirms Positive Agrarius Agricultural Trial Results, Advancing Toward Commercialization
Mountain Valley MD Provides Business Update, Advances Commercialization Strategies
Mountain Valley MD Holdings Announces Changes to Board of Directors
Mountain Valley MD demonstrates commercialization progress across key sectors in 2024 update
Mountain Valley MD Provides Year-End Business Update, Advances Commercialization Strategies
Mountain Valley MD shares updates from ‘transformative' six months
Mountain Valley MD Provides Business Update, Advances Commercialization
C-SPAN To Visit Contra Costa School, Honor Student Documentary Winners
Mountain Valley MD acquires exclusive license for AgTech product Agrarius
Mountain Valley MD acquires exclusive license for AgTech product Agrarius
Mountain Valley MD Announces Acquisition of Exclusive License for Agrarius, Launch of Performance Guarantee Program
Mountain Valley MD Announces Stock Option Grant
Mountain Valley MD advances commercialization priorities across core business lines
Mountain Valley MD Provides Business Update, Appoints New CFO